Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

• Status: Completed
• Trial end date: 2012-02-16

Summary

This is a 2-phase retrospective database study, using both case-cohort and inception (intention-to-treat) cohort analyses to evaluate any association between oral treatments for osteoporosis and the risk of esophageal cancer in women.

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Collaborator: World Health Information Science Consultants, LLC
• Treatments: Alendronate; Diphosphonates; Etidronic Acid; Ibandronic Acid; Raloxifene Hydrochloride; Risedronate Sodium; Risedronic Acid